Crisaborole: a dermatologic perspective
Crisaborole is a non-steroidal boron-containing topical phosphodiesterase-4 inhibitor that has been approved by the US-FDA for the treatment of atopic dermatitis in children (> 3 months of age) and adults. More recently, its efficacy has been outlined in the treatment of many other dermatoses, in...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sociedade Portuguesa de Dermatologia e Venereologia
2025-04-01
|
| Series: | Revista da Sociedade Portuguesa de Dermatologia e Venereologia |
| Subjects: | |
| Online Access: | https://www.portuguesejournalofdermatology.com/frame_eng.php?id=241 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|